Diffuse large B-cell lymphoma trials in Moldova

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  Where

  Chisinau

  Age

  18 years and over

  People

  689 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT05006716 · EU 2022-502157-33-00
• Phase 1Taking people
  Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

  Where

  Chisinau

  Age

  18 years and over

  People

  85 worldwide

  Run by

  Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

  See details and how to joinNCT06980116 · EU 2024-516869-36-00
• Phase 1Taking people
  Study of SGR-1505 in Mature B-Cell Neoplasms

  Where

  Chisinau

  Age

  18 years and over

  People

  98 worldwide

  Run by

  Schrödinger, Inc.

  See details and how to joinNCT05544019 · EU 2023-505204-34-00